NASDAQ:VECT
VectivBio
- Stock
locale
Switzerlandmarket
STOCKSindustry
Biotechnologywebsite
vectivbio.comipo date
Apr 08, 2021
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with short bowel syndrome-intestinal fail...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus